4510-16-1

4510-16-1 structure

4510-16-1 structure

Name: Prostaglandin F2β
Chemical Name: prostaglandin F2β
CAS Number: 4510-16-1
Molecular Formula: C₂₀H₃₄O₅
Molecular Weight: 354.48
Catalog: Research Areas Others
Create Date: 2018-05-26 08:00:00
Modify Date: 2024-04-02 19:48:40
(5R)-Dinoprost is a metabolite produced by cyclooxygenase metabolism of arachidonic acid. (5R)-Dinoprost (Prostaglandin F2β) induces dose-dependent release of hexose containing mucin[1][2].

Name	prostaglandin F2β
Synonyms	Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9β,11α,13E,15S)- (5Z,9β,11α,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid 9BETA, 11ALPHA-PROSTAGLANDIN F2 prostaglandin F2beta Prostaglandin F2β

Description	(5R)-Dinoprost is a metabolite produced by cyclooxygenase metabolism of arachidonic acid. (5R)-Dinoprost (Prostaglandin F2β) induces dose-dependent release of hexose containing mucin[1][2].
Related Catalog	Research Areas >> Others
References	[1]. Lamont JT, et, al. Cysteamine and prostaglandin F2 beta stimulate rat gastric mucin release. Gastroenterology. 1983 Feb;84(2):306-13. [2]. Jang Y, et, al. Molecular mechanisms underlying the actions of arachidonic acid-derived prostaglandins on peripheral nociception. J Neuroinflammation. 2020 Jan 22;17(1):30.

Density	1.2±0.1 g/cm3
Boiling Point	531.0±50.0 °C at 760 mmHg
Melting Point	105-106ºC
Molecular Formula	C₂₀H₃₄O₅
Molecular Weight	354.48
Flash Point	289.0±26.6 °C
Exact Mass	354.240631
PSA	97.99000
LogP	2.14
Vapour Pressure	0.0±3.2 mmHg at 25°C
Index of Refraction	1.569

CHEMICAL IDENTIFICATION

RTECS NUMBER :: MJ9658000

CHEMICAL NAME :: 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)- , stereoisomer

CAS REGISTRY NUMBER :: 4510-16-1

LAST UPDATED :: 198910

DATA ITEMS CITED :: 1

MOLECULAR FORMULA :: C20-H34-O5

MOLECULAR WEIGHT :: 354.54

WISWESSER LINE NOTATION :: L5TJ AQ B2U4VQ C1U1YQ5 DQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 10 mg/kg

SEX/DURATION :: female 19 day(s) after conception

TOXIC EFFECTS :: Reproductive - Maternal Effects - parturition

REFERENCE :: BJPCBM British Journal of Pharmacology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.34- 1968- Volume(issue)/page/year: 36,188P,1969